ClinicalTrialsFinder

Phase 1 Plaque Psoriasis Clinical Trials

9 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–9 of 9 trials

Recruiting
Phase 1

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Hidradenitis SuppurativaPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL20 enrolled12 locationsNCT06888193
Recruiting
Phase 1

A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

Healthy VolunteerPlaque Psoriasis
Usynova Pharmaceuticals Ltd.124 enrolled1 locationNCT07038720
Recruiting
Phase 1Phase 2

A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis
Chipscreen Biosciences, Ltd.220 enrolled11 locationsNCT07129382
Recruiting
Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Plaque Psoriasis
Ascletis Pharma (China) Co., Limited94 enrolled1 locationNCT07024602
Completed
Phase 1

First-in-Human Study of Oral SDC-1801 in Healthy Adults and Adults with Plaque Psoriasis (Part 3 - Food Effects)

Plaque Psoriasis
Pharmaceutical Solutions Australia Pty Ltd16 enrolled1 locationACTRN12623000419662
Not Yet Recruiting
Phase 1

First-in-Human Study of Oral SDC-1801 in Healthy Adults and Adults with Plaque Psoriasis (Part 4 - Adults with Plaque Psoriasis)

Plaque Psoriasis
Pharmaceutical Solutions Australia Pty Ltd12 enrolled2 locationsACTRN12623000417684
Completed
Phase 1

First-in-Human Study of Oral SDC-1801 in Healthy Adults and Adults with Plaque Psoriasis (Parts 1 and 2)

Plaque Psoriasis
Pharmaceutical Solutions Australia Pty Ltd80 enrolled1 locationACTRN12623000416695
Recruiting
Phase 1

A Phase 1 Single Dose Study to Assess the Pharmacokinetics and Safety of the Biosimilar Ustekinumab Healthy Volunteers

Plaque Psoriasis
NeuClone Proprietary Limited210 enrolled3 locationsACTRN12619001473156
Completed
Phase 1

A Phase I Study to evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic profile of single and multiple dose of ANB019 in Healthy Subjects and Psoriasis Patients.

Generalized Pustular PsoriasisPlaque PsoriasisPalmoplantar Pustolosis
AnaptysBio Pty Ltd87 enrolled1 locationACTRN12617000369325